D-Index & Metrics Best Publications
Microbiology
UK
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 115 Citations 65,639 640 World Ranking 84 National Ranking 11
Medicine D-index 121 Citations 71,289 817 World Ranking 1991 National Ranking 205

Research.com Recognitions

Awards & Achievements

2023 - Research.com Microbiology in United Kingdom Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Andrew N. Phillips mainly focuses on Internal medicine, Immunology, Acquired immunodeficiency syndrome, Viral load and Cohort study. He interconnects Sida and Surgery in the investigation of issues within Internal medicine. His research in Immunology intersects with topics in Gastroenterology, Proportional hazards model and Antiretroviral therapy.

Andrew N. Phillips has included themes like Incidence, Disease, Hazard ratio, Seroconversion and Survival analysis in his Acquired immunodeficiency syndrome study. He combines subjects such as Zidovudine, Regimen, Pharmacotherapy, Ritonavir and Drug resistance with his study of Viral load. His Cohort study study combines topics in areas such as Epidemiology, Mortality rate, HPTN 052, Retrospective cohort study and Risk factor.

His most cited work include:

  • CD4+ count-guided interruption of antiretroviral treatment. (1814 citations)
  • Meta-analysis: Principles and procedures (1664 citations)
  • Combination antiretroviral therapy and the risk of myocardial infarction (1490 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Immunology, Acquired immunodeficiency syndrome, Viral load and Cohort are his primary areas of study. As part of his studies on Internal medicine, Andrew N. Phillips often connects relevant areas like Surgery. His Immunology research includes elements of Gastroenterology and Epidemiology.

His Acquired immunodeficiency syndrome research incorporates elements of Proportional hazards model, Seroconversion, Incidence and Pediatrics. His study in Viral load is interdisciplinary in nature, drawing from both Demography, Efavirenz, Antiretroviral therapy and Drug resistance. His Confidence interval research includes elements of Odds ratio and Poisson regression.

He most often published in these fields:

  • Internal medicine (38.73%)
  • Immunology (30.52%)
  • Acquired immunodeficiency syndrome (28.40%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (38.73%)
  • Viral load (26.06%)
  • Demography (9.74%)

In recent papers he was focusing on the following fields of study:

Andrew N. Phillips focuses on Internal medicine, Viral load, Demography, Acquired immunodeficiency syndrome and Confidence interval. Andrew N. Phillips regularly links together related areas like Oncology in his Internal medicine studies. His Viral load research is multidisciplinary, incorporating perspectives in Transmission, Prospective cohort study, Randomized controlled trial and Antiretroviral therapy.

His research in Acquired immunodeficiency syndrome focuses on subjects like Regimen, which are connected to Efavirenz, Dolutegravir and Drug resistance. He usually deals with Confidence interval and limits it to topics linked to Poisson regression and Cohort study and Ethnic group. Andrew N. Phillips combines subjects such as Ovarian cancer and Surgery with his study of Cohort.

Between 2015 and 2021, his most popular works were:

  • Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. (970 citations)
  • Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy (672 citations)
  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study (249 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

The scientist’s investigation covers issues in Internal medicine, Demography, Viral load, Acquired immunodeficiency syndrome and Men who have sex with men. His biological study spans a wide range of topics, including Immunology and Oncology. Andrew N. Phillips has researched Viral load in several fields, including Absolute risk reduction, Health care, Randomized controlled trial, Antiretroviral therapy and Social support.

His Acquired immunodeficiency syndrome research incorporates themes from Epidemiology, Cohort study, Program evaluation, Proportional hazards model and Hazard ratio. His Cohort study research is multidisciplinary, incorporating elements of Poisson regression and Pediatrics. His research investigates the connection between Proportional hazards model and topics such as Confidence interval that intersect with issues in Cohort.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

CD4+ count-guided interruption of antiretroviral treatment.

Wafaa El-Sadr;Wafaa El-Sadr;Jens D Lundgren;James Neaton;Fred Gordin.
The New England Journal of Medicine (2006)

2887 Citations

Combination antiretroviral therapy and the risk of myocardial infarction

Nina Friis-Møller;Caroline A Sabin;Rainer Weber;Antonella d'Arminio Monforte.
The New England Journal of Medicine (2003)

2445 Citations

Class of antiretroviral drugs and the risk of myocardial infarction.

Nina Friis-Moller;Peter Reiss;Caroline A. Sabin;Rainer Weber.
The New England Journal of Medicine (2007)

2066 Citations

Meta-analysis: Principles and procedures

Matthias Egger;George Davey Smith;Andrew N Phillips.
BMJ (1997)

2025 Citations

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips.
The Lancet (2002)

2020 Citations

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Sheena McCormack;David T. Dunn;Monica Desai;David I. Dolling.
The Lancet (2016)

1693 Citations

Changing patterns of mortality across Europe in patients infected with HIV-1.

A Mocroft;S Vella;TL Benfield;A Chiesi.
The Lancet (1998)

1652 Citations

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

A Mocroft;B Ledergerber;C Katlama;O Kirk.
The Lancet (2003)

1582 Citations

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

Rainer Weber;Caroline A Sabin;Nina Friis-Møller;Peter Reiss.
JAMA Internal Medicine (2006)

1452 Citations

Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study

Nina Friis-Møller;Rainer Weber;Peter Reiss;Rodolphe Thiebaut.
AIDS (2003)

1327 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Andrew N. Phillips

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 240

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 229

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 224

Caroline Sabin

Caroline Sabin

University College London

Publications: 212

Dominique Costagliola

Dominique Costagliola

Sorbonne University

Publications: 209

David A. Cooper

David A. Cooper

University of New South Wales

Publications: 195

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 181

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 178

Antonella d'Arminio Monforte

Antonella d'Arminio Monforte

University of Milan

Publications: 174

Amy C. Justice

Amy C. Justice

Yale University

Publications: 171

Matthias Egger

Matthias Egger

University of Bern

Publications: 166

Manuel Battegay

Manuel Battegay

University Hospital of Basel

Publications: 166

Peter Reiss

Peter Reiss

University of Amsterdam

Publications: 151

Amanda Mocroft

Amanda Mocroft

University College London

Publications: 147

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 145

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 145

Trending Scientists

Umberto Spagnolini

Umberto Spagnolini

Polytechnic University of Milan

Takahito Ono

Takahito Ono

Tohoku University

Hai Wang

Hai Wang

Stanford University

Shu Wang

Shu Wang

Chinese Academy of Sciences

Balachandran Unni Nair

Balachandran Unni Nair

Central Leather Research Institute

Barbara Baker

Barbara Baker

University of California, Berkeley

Paul B. Fisher

Paul B. Fisher

Virginia Commonwealth University

David S. Wethey

David S. Wethey

University of South Carolina

Anson W. Mackay

Anson W. Mackay

University College London

Jacqueline F. N. van Leeuwen

Jacqueline F. N. van Leeuwen

University of Bern

Olav Rune Godø

Olav Rune Godø

Norwegian Institute of Marine Research

Rick C.S. Lin

Rick C.S. Lin

University of Mississippi Medical Center

Kees L. M. C. Franken

Kees L. M. C. Franken

Leiden University Medical Center

Robert B. Cairns

Robert B. Cairns

University of North Carolina at Chapel Hill

James Thomas

James Thomas

University College London

Stefano Frixione

Stefano Frixione

European Organization for Nuclear Research

Something went wrong. Please try again later.